Kobayashi Pharmaceutical Co., Ltd. (TSE:4967) announces a share repurchase program. Under the program, the company will repurchase up to 1,265,800 shares, representing 1.64% of its issued share capital for ¥9,999.82 million. The shares will be repurchased at a price of ¥7,200 per share. The purpose of the program is to further return profits to shareholders and implement a flexible capital policy that responds to changes in the business environment. The program is valid till November 2, 2022. As of September 30, 2022, the company had 77,279,714 shares issued (excluding treasury stock) and 4,770,286 shares in treasury.

On February 17, 2023, the company announced the final number of shares repurchased after the determination of post-adjustment. Under the program, the final number of shares to be acquired are 1,151,700 shares.